Nexalin Technology (NXL) Inventory Average (2022 - 2026)
Nexalin Technology's (NXL) quarterly Inventory Average came in at $155481.0 in Q1 2026, down 11.11% year-on-year from $174915.5 in Q1 2025, and up 6.6% quarter-over-quarter from $145849.0 in Q4 2025.
Nexalin Technology (NXL) Inventory Average (2022 - 2026) Analysis & Trends
Nexalin Technology's Inventory Average history runs 5 years deep, the most recent figure standing at $155481.0 for Q1 2026.
- On a quarterly basis, Inventory Average fell 11.11% year-over-year to $155481.0 in Q1 2026; TTM through Mar 2026 was $155481.0, a 11.11% decrease from a year earlier, with the FY2025 full-year figure at $153025.5, down 7.54% from the prior year.
- Inventory Average advanced to $155481.0 in Q1 2026 per NXL's latest filing, from $145849.0 in the prior quarter.
- Across five years, Inventory Average topped out at $174915.5 in Q1 2025 and bottomed at $145849.0 in Q4 2025.
- The 5-year median for Inventory Average is $156919.8 (2023), against an average of $158939.5.
- Biggest YoY gain for Inventory Average was 16.54% in 2025; the steepest drop was 12.39% in 2025.
- Year by year, Inventory Average stood at $153220.5 in 2022, then grew by 2.81% to $157519.5 in 2023, then increased by 5.69% to $166476.5 in 2024, then fell by 12.39% to $145849.0 in 2025, then advanced by 6.6% to $155481.0 in 2026.
- Per Business Quant, the three latest NXL Inventory Average figures stand at $155481.0 (Q1 2026), $145849.0 (Q4 2025), and $166599.5 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 5.36 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.13 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.12 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 661.35 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.49 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 2.29 Bn |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 | 155,481.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 155,481.00 |
| Dec 31, 2025 | 145,849.00 |
| Sep 30, 2025 | 166,599.50 |
| Jun 30, 2025 | 174,113.50 |
| Mar 31, 2025 | 174,915.50 |
| Dec 31, 2024 | 166,476.50 |
| Sep 30, 2024 | 151,758.00 |
| Jun 30, 2024 | 149,404.50 |
| Mar 31, 2024 | 155,044.00 |
| Dec 31, 2023 | 157,519.50 |
| Sep 30, 2023 | 159,313.00 |
| Jun 30, 2023 | 159,138.50 |
| Mar 31, 2023 | 156,320.00 |
| Dec 31, 2022 | 153,220.50 |